4//SEC Filing
Iyer Radhakrishnan P. 4
Accession 0000905718-20-001129
CIK 0001566373other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 11:10 AM ET
Size
17.9 KB
Accession
0000905718-20-001129
Insider Transaction Report
Form 4
Iyer Radhakrishnan P.
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2020-11-19+12,500→ 125,312 total - Sale
Common Stock
2020-11-20$4.76/sh−175$833→ 125,137 total - Exercise/Conversion
Restricted Stock Units
2020-11-19−5,000→ 0 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2020-11-19+5,000→ 112,812 total
Holdings
- 12,500(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited.
- [F3]These shares are directly held by Nandakumar R & Suhasini R Iyer et al tr Radhakrishnan P Iyer TR DTD 7/8/14 (the "Trust"). The Reporting Person and the Reporting Person's immediate family members are beneficiaries of the Trust, and the Reporting Person is a trustee of the Trust.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001664423
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 11:10 AM ET
- Size
- 17.9 KB